We are testing a new system for linking grants to scientists.
The funding information displayed below comes from the
NIH Research Portfolio Online Reporting Tools and the
NSF Award Database.
The grant data on this page is limited to grants awarded in the United States and is thus partial. It can nonetheless be used to understand how funding patterns influence mentorship networks and vice-versa, which has deep implications on how research is done.
You can help! If you notice any innacuracies, please
sign in and mark grants as correct or incorrect matches.
Sign in to see low-probability grants and correct any errors in linkage between grants and researchers.
High-probability grants
According to our matching algorithm, Emil J. Freireich is the likely recipient of the following grants.
| Years |
Recipients |
Code |
Title / Keywords |
Matching
score |
| 1985 — 1991 |
Freireich, Emil J |
R35Activity Code Description:
To provide long term support to an experienced investigator with an outstanding record of research productivity. This support is intended to encourage investigators to embark on long-term projects of unusual potential. |
Therapy and the Biology of Human Leukemia @ University of Texas Md Anderson Can Ctr
neoplasm /cancer therapy; leukemia; human subject;
|
0.949 |
| 2003 — 2004 |
Freireich, Emil J |
K12Activity Code Description:
For support to a newly trained clinician appointed by an institution for development of independent research skills and experience in a fundamental science within the framework of an interdisciplinary research and development program. |
Patient-Oriented Cancer Research Training Program @ University of Texas Md Anderson Can Ctr
DESCRIPTION (provided by applicant): The specific aim of this proposal is training physicians to become successful patient-oriented research scientists. The major factors limiting the pool of POR scientists are the time constraints of patient care and the lack of support. This training grant is designed specifically to address these needs. By providing stipend and research support, trainees will be guaranteed protected time and have the opportunity to participate in a formal training program as full time students. The program is designed to train physicians who have completed their subspecialty training in oncology and are board eligible and/or certified. The program will consist of 2 years of intensive training. Each trainee will have two mentors, a laboratory based scientist and a POR physician scientist, to assure that the trainee learns to translate laboratory research data to the clinic and the reverse, that is to be able to explore in the laboratory fundamental findings from the clinic. The program will include formal course work in clinical trials, clinical epidemiology, statistics and molecular and cellular biology. The course work will be augmented by conduct of a research project including preparing the protocol, obtaining research committee and institutional review board approvals, analyzing the data, writing and publishing manuscripts, and preparing and submitting research grants. The Principal Investigator and the 3 Co-Principal Investigators will be responsible for program management. The overall program will be supervised by an Executive Committee, consisting of the Principal Investigator and the 3 Co-Principal Investigators, assisted by the V/P for Translational Research, the V/P for Education, the V/P for Institutional Diversity and the Program Director for Education Research and Assessment. An Advisory Committee consisting of the clinical division heads and the basic science department chairmen will oversee and evaluate progress of the grant. A comprehensive panel of mentors in all disciplines is available for student supervision and instruction. The program will prepare oncology physician specialists for careers in academic patient-oriented research in oncology.
|
0.949 |